ライフサイエンスコーパス: asialofetuin

1 from ribonuclease B and linkage isomers from asialofetuin.

2 ch was inhibited by 3-27-fold by lactose and asialofetuin.

3 < 0.0001) by rabbit anti-ASGR1 antibody and asialofetuin.

4 spherical shape with a diameter of 15-30 nm; asialofetuin, a natural ligand for the asialoglycoprotei

5 onventional liposomes (CL) were labeled with asialofetuin (AF), an asialoglycoprotein.

6 utant had a one and one-half log decrease in asialofetuin and cell binding relative to the parent dou

7 and cell supernatants were characterized for asialofetuin and cell binding, immunoreactivites, abilit

8 bdomains 1 alpha, 2 alpha, and 2 gamma bound asialofetuin and cells similarly to the parent 1 alpha,

9 d high affinities and specificities for both asialofetuin and T antigen in solution.

10 high riproximin binding, the NA3-presenting asialofetuin and the clustered Tn-rich asialo-bovine sub

11 variety of glycoproteins, including RNase B, asialofetuin, and transferrin, and the HIV envelope glyc

12 When using asialofetuin as model glycoprotein, a minimum amount of

13 ated module can bind the plasma glycoprotein asialofetuin as well as the polysaccharide receptors pre

14 um albumin (Kd = 5 nM for MAP-P30 binding to asialofetuin) as well as free T-antigen disaccharide in

15 rtained by determining the IC(50) values for asialofetuin (ASF) and for bovine serum albumin derivati

16 isaccharide Galalpha1-3GalNAc (TF-AuNP), (2) asialofetuin (ASF) containing both LacNAc (Galbeta1-4Glc

17 ive cooperativity in the ITC binding data of asialofetuin (ASF), a glycoprotein that possesses nine L

18 Preincubation of PHUECs in asialofetuin (ASF), an ASGP-R ligand, significantly redu

19 on of galectin-3 with the model glycoprotein asialofetuin (ASF), using a fluorescence anisotropy assa

20 chelate acceptor beads, whereas biotinylated asialofetuin (biotin-ASF), a galectin-3 nanomolar bindin

21 IgG, anti-RHL-1 IgG, asialoorosomucoid, and asialofetuin competitively blocked the binding of 125I-L

22 cin attachment to HeLa cells and immobilized asialofetuin, due to framework residues (FR3) that occup

23 lycan types was studied using bovine fetuin, asialofetuin, IgG, ribonuclease B, and alpha-1 acid glyc

24 As expected, when applied to asialofetuin (known to contain galactose only in the pyr

25 y the ability of both P30 and P10 to inhibit asialofetuin-mediated melanoma cell aggregation in vitro

26 Additionally, asialofetuin, not fetuin, inhibited platelet phagocytosi

27 ies and affinities to T antigen displayed on asialofetuin or conjugated to bovine serum albumin (Kd =

28 e passage through two affinity columns, i.e. asialofetuin-Sepharose and invertase-Sepharose.

29 Asialofetuin, the beta1-galactosyl-terminated glycoprote

30 odel glycoproteins (RNase B, avidin, fetuin, asialofetuin, transferrin, and AGP) as well as a clade C

31 tetramethylrhodamine isothiocyanate labeled asialofetuin (TRITC-AF) as a ST substrate and fluorescei

32 and reduce the amount of toxin available to asialofetuin type II, which is used as a model to study

33 .01) by prior intravenous infusion of excess asialofetuin, which can selectively bind to the ASGP-R.